Argos touts cancer trial results; new tool at Laser Eye Center; Alien Skin updates Photoshop plug-in
• Durham-based Argos Therapeutics says Phase 2 data for proposed renal cell carcinoma treatment AGS-003 shows promise “The AGS-003 and sunitinib combination study was a single-stage, Phase 2 design, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback